![Peter DeNardo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Peter DeNardo worked as the Director of Investor Relations & Communications at Amyris, Inc. from 2015 to 2020.
He also served as the Head of Investor Relations at Standard BioTools, Inc.
Anciens postes connus de Peter DeNardo
| Sociétés | Poste | Fin |
|---|---|---|
| AMYRIS, INC. | Investor Relations Contact | 01/09/2020 |
| STANDARD BIOTOOLS INC. | Investor Relations Contact | 04/04/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Standard BioTools, Inc.
 Standard BioTools, Inc. Medical SpecialtiesHealth Technology Manufactures and markets innovative technologies and tools for life sciences research | Health Technology |
Amyris, Inc.
 Amyris, Inc. Chemicals: SpecialtyProcess Industries Operates as a biomanufacturing company that uses renewable biological chemistry | Process Industries |
